Formulation Development and Evaluation of Transfero-somes Nano Gel Loaded with Levocetirizine Transfero-somes

DOI:

https://doi.org/10.37285/ijpsn.2021.14.2.4

Authors

  • Mounika S Bharath
  • Bhushan R rane
  • Ashish S Jain

Abstract

A new drug delivery technology called transferosomes were came into existence which is an artificial vesicle designed to show the characteristics of a cell vesicle suitable for controlled and potentially directed drug delivery. Transferosome is a highly flexible and stress- responsive compound, complex compound and highly deformed vesicle with an aqueous core surrounded by the complex lipid bilayer thus enabling it to deliver both hydrophilic and hydrophobic drug. Urticaria is a general condition distinguished as brief erythematous and oedematous plaques or papules with defined erythematous borders and central clearing, identified as hives/wheals. Levocetirizine which is used for the treatment is a H1 anti histamine that is actively used in treatment of urticaria. The aim of the present research work was to investigate the potential of transferosome formulations for transdermal delivery of  levocetirizine. The transferosomes were formulated by lipid film hydration technique using Rotary vacuum Evaporator. In the present work levocetirizine vesicle was efficaciously formulated using an appropriate ratio of tween 80 and soya lecithin and was incorporated into gel since gel formulations are easy to administer and patient compliance. Levocetirizine transferosomes was evaluated for vesicle characteristicslike zeta potential, poly-dispersibility index, TEM, and stability study. Theaverage sizes of transferosome were found to be 566.6nm and poly dispersity index (PI) was found to be 0.532, zeta potential of the transferosome was found to be -2.3 mV which indicates that transferosome formulation is stable. Levocetirizine gel was prepared by using various concentrations of Carbopol 934 and is evaluated for their gel characteristics like pH, viscosity, Spreadability, extrudability, homogeneity, drug content, diffusion etc. Gel containing 2% Carbopol show best and promising results. Levocetirizine transferosomal gel were efficaciously formulated by utilizing levocetirizine transferosome which was prepared by thin film hydration method by using soya lecithin and tween 80 in the ratio 85:15. Other Oral formulation used in treatment for urticaria have disadvantage like poor bioavailability, 1st pass metabolism, patient non-compliance etc. Transferosome nano gel loaded with levocetirizine transferosome was found to be more effective than other oral formulations used in treatment for urticaria since transferosome are capable of passing through lipid layer and delivering drug into systemic circulation with maximum bioavailability.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Transferosome, Transferosomal gel, Levocetirizine, Carbopol 934, Urticaria

Downloads

Published

2021-05-01

How to Cite

1.
Bharath MS, rane BR, Jain AS. Formulation Development and Evaluation of Transfero-somes Nano Gel Loaded with Levocetirizine Transfero-somes. Scopus Indexed [Internet]. 2021 May 1 [cited 2024 Sep. 8];14(2):5383-95. Available from: https://ijpsnonline.com/index.php/ijpsn/article/view/1907

Issue

Section

Research Articles

References

Ahad A, Aqil M, and Ali A (2014). Investigation of antihypertensive activity of carbopol valsartan transdermal gel containing 1, 8- cineole. Int J BiolMacromol 64:144-149.

Bala TS (2017). Formulation and in vitro evaluation of topical ethosomal gels of miconazole nitrate.World J Pharm Pharm Sci 6(8): 1882-1898.

Benson HA (2006). Transfersomes for transdermal drug delivery.Exp Opin Drug Deliv 3(6): 727-737.

Cevc G, and Blume G (2001). New highly efficient formulation of diclofenac for the topical, transdermal administration in ultra- deformable drug carriers, transfersomes. Biochimica Et Biophysica Acta1 514(2): 191–205

Cevc G (2002). Self- regulating smart carriers for non-invasive and targeted drug delivery. Cell Mol Biol Lett 7(2): 224–225.

Chandira RM, Kumar KP, Jayakar B et al. (2010). Design, Development and Formulation of Antiacne Dermatological Gel. J Chem Pharm Res 2(1): 401-404.

Das B, Sen SO, Maji R, Nayak AK, and Sen KK (2017). Transferosomal gel for transdermal delivery of risperidone: Formulation optimization and ex vivo permeation. J Drug Delivery Sci Technol 38: 59-71.

Devalia JL, de Vos C, Hanotte F, and Baltes E (2001). A randomized double-blind crossover comparison among cetirizine, levoce- tirizine and UCB 28557 on histamine-induced cutaneous responses in healthy adult volunteers. Allergy 56(1): 50–57.

Dixit G, Misal G, gulkari V, and Upadhye K (2013). Formulation and evaluation of polyherbal gel for anti-inflammatory activity. Int J Pharm Sci Res 4(3): 1186-1191.

Goyal S (2011). Novel Anti-Inflammatory Topical Herbal Gels Containing with aniasomnifera and Boswellia serrata. Int J Pharm and Bio Archives 2(4): 1087-1094.

Gupta A, Prajapati SK, Balamurugan M, Singh M, and Bhatia D (2007). Design and development of a proniosomal transdermal drug delivery system for Captopril. Trop J Pharma Res 6(2): 687–693.

Herrmann WA, and Geertsen MS (2009). Efficacy and safety of lornoxicam compared with placebo and diclofenac in acute sciatica/lumbo-sciatica: an analysis from a randomised, double- blind, multicentre, parallel-group study. Int J Clin Pract 63(11): 1613–1621.

Jain S, Mishra D, Kuksal A, et al. (2006). Vesicular approach for drug delivery into or across the skin: current status and future prospects. Pharm Online 1: 1–32.

Jain S, Padsalg BD, Patel AK, and Moale V (2007). Formulation development and evaluation of fluconazole gel in various polymer bases. Asian J Pharm 1(8): 63-68.

Kamani P, Parikh K, Kapadia R, and Sawant K (2019). Phospholipid based ultra-deformable nanovesicular gel for transcutaneous application: QbD based optimization, characterization and pharmacodynamic profiling. J Drug Delivery Sci Technol 51: 152-163.

Kasar MP, Kale K, and Phadtar DG (2018). Formulation and evaluation of topical antifungal gel containing itraconazole. Int JCurrPharm Res 10(4): 71-74.

Kulkarni PR, Yadav JD, Vaidya KA, and Gandhi PP (2011). Transferosomes: An emerging tool for transdermal drug delivery. Int J Pharm Sci Res 2(4): 735-741.

Kumar L, and Verma R (2010). In vitro Evaluation of Topical Gel Prepared using Natural Polymer. Int J Drug Delivery 2(1): 58- 63.

Kumar A, Pathak, K, and Bali V (2012). Ultra-adaptable nano vesicular systems: a carrier for systemic delivery of therapeutic agents. Drug Discovery Today 17(21-22): 1233–1241.

Malakar J, Sen SO, Nayak AK, and Sen KK (2012). Formulation, optimization, and evaluation of transferosomal gel for transdermal insulin. Saudi Pharm J 20(4): 355-363

Malakar J, Basu A, and Nayak AK (2014). Candesartan cilexitil microemulsions for transdermal delivery: Formulation, in vitro

skin permeation and stability assessment. Curr Drug Deliv

(3): 313-321.

Meghraby GM, Williams AC, and Barry BN (1999). Skin delivery

of oestradiol from deformable and traditional liposomes: mechanistic study. J Pharm Pharmacol 51(10): 1123-1124.

Mei Z, Chen H, Wang T, Yang Y, and Yang X (2003). Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur J Pharm Biopharm 56(2): 189-96.

Mishra D, Dubey V, Asthana A, Saraf DK, and Jain NK (2006). Elastic liposomes mediated transcutaneous immunization against hepatitis B. Vaccine 24(22): 4847-4855

Mishra US, Murthey PN, Mishra D, and Sahu K (2011). Formulation and standerdisation of herbal gel containing methanolic extract of CalophyllumInophyllum. Am J PharmTech Res 1(1): 276-289.

Morrow D, Garland M, McCarron PA, Woolfson AD, and Donnelly RF (2007). Innovative drug delivery strategies for topical photodynamic therapy using porphyrin precursors. J. Environ Pathol Toxicol. Oncol 26(2): 105–116.

Morrow DIJ, McCarron PA, Woolfson AD, et al. (2007). Innovative strategies for enhancing topical and transdermal drug delivery. Open Drug Deliv J 1: 36–59.

Mutimer MN, Riffkin C, Hill JA, Glickman MN, and Cyr GN (1956). Modern Ointment Bases Technology – II – Comparative Evaluation of Bases. J Am Pharm Assoc 45(4): 212-218.

Nayak AK, Mohanty B, and Sen KK (2010). Comparative evaluation of in vitro diclofenac sodium permeability across excised mouse skin from different common pharmaceutical vehicles. Int J PharmTech Res 2(1): 920-930.

Nazar MF, Khan AM, and Shah SS (2009). Microemulsion systems with improved loading of piroxicum. A study of microstructure. AAPS Pharm Sci Tech 10(4): 1286-1294.

Nettis E, Colanardi M, Barra L, Ferrannini, Antonio, Vacca A, Tursi, and Alfredo (2006). Levocetirizine in the treatment of chronic idiopathic urticaria: A randomized, double-blind, placebo- controlled study. Br J Dermatol 154(3): 533-538.

Pasarin D, and Rovinaru C (2019). Separation method of the eggshell membrane from eggshell. Proceedings-MDPI 29:122.

Qushawy M, Nasr A, Abd-Alhaseeb M, and Swidan S (2018). Design. Optimization and Characterization of a Transfersomal Gel Using Miconazole Nitrate for the Treatment of Candida Skin Infections. Pharmaceutics 10(1): 26.

Rai S, Pandey V, and Rai G (2017). Transfersomes as versatile and flexible nanovesicular carriers in skin cancer therapy: the state of the art. Nano Rev Experim 8(1): 1-15.

Ramchandani U, and Sangameswaran B (2013). Formulation and evaluation of topical gel of ketoprofen using different polymers. Int J Pharm Biol Arch 4(2): 323-6.

Rathod HJ and Mehta DP (2015). A Review on Pharmaceutical Gel.

Int J Pharm Sci 1(1): 33-47.

Sera UV, and Ramana M (2006). In vitro skin absorption and drug release – a comparison of four commercial hydrophilic gel preparations for topical use. The Indian Pharmacist 73: 356-60.

Shah KA, Date AA, Joshi MD, and Patravale VB (2007). Solid lipid nanoparticles (SLN) of tretinoin: Potential in topical delivery. Int J Pharm 345:163-71.

Sharma A (2010). Recent advances in NDDS (Novel drug delivery systems) for delivery of Anti-HIV drugs. Res J Pharm Bio Chem Sci 1(3): 78-88.

Singh MP, Nagori BP, Shaw NR, Tiwari M, and Jhanwar B (2013). Formulation Development & Evaluation of Topical Gel Formulations Using Different Gelling Agents and its Comparison with Marketed Gel Formulation. Int J Pharm 3(3): 1-10.

Tillement JP (1995). A low distribution volume as a determinant of efficacy and safety for histamine (H1) antagonist. Allergy 50 (suppl 24): 12–16.

Trotta M, Peira E, Debernardi G, and Gallarate M (2002). Elastic liposomes for skin delivery of dipotassium, glycyrrhizinate. Int J Pharm 241(2): 319-327.

Verma R (2007). In vitro skin absorption and drug release-a

comparison of four commercial hydrophilic gel preparations for topical use. Eur J Pharm Biopharm 67(5): 398-405.

Walve JR, Bakliwal SR, Rane BR, and Pawar SP (2011). Transfersomes: A surrogated carrier for transdermal drug delivery system. Int J App Bio Pharm Tech 2(1): 204-213.

Zafaruddin MD, Laxmi MV and Kuchana V (2015). Design and characterization of transferosomal gel of repaglinide. Int Res J Pharm 6(1): 38-42.